| COVID-19 positive patients data |
|
|
|
| Time after surgery to COVID-19 diagnosis (days) |
|
|
13 |
| Amount of time between the last date of laboratory samplings and COVID-19 diagnosis (days) |
|
|
1.21 |
| White blood cells (X109/L) |
|
|
7.9±3.2 |
| Neutrophils (%) |
|
|
67.2±10.1 |
| CRP (mg/L) |
|
|
91.1±54.5 |
| Hemoglobin (g/L) |
|
|
103.2±10.6 |
| Symptoms after COVID-19 positive diagnosis: |
|
|
|
| Dry cough |
3 |
21.4 |
|
| Fever >37.5°C |
9 |
64.3 |
|
| Need for oxygen therapy |
6 |
40 |
|
| Dyspnea |
4 |
28.6 |
|
| No symptoms |
5 |
35.7 |
|
| Readmission to ICU |
3 |
21.4 |
|
| Reintubation after readmission to ICU |
2 |
14.3 |
|
| After COVID-19 positive diagnosis |
|
|
|
| Average time of laboratory sampling after COVID-19 diagnosis (days) |
|
|
8.75 |
| Ferritin (pg/L) |
|
|
311.1±345.9 |
| Lactate dehydrogenase (U/L) |
|
|
350.1±146.8 |
| D-dimer (mg/L) |
|
|
3±1.4 |
| White blood cells (X109/L) |
|
|
7±1.8 |
| Platelets (X109/L) |
|
|
348.1±152 |
| Hemoglobin (g/L) |
|
|
103.6±8.7 |
| CRP (mg/L) |
|
|
53.9±54.7 |
| Chest computed tomography |
4 |
28.6 |
|
| Treatment: |
|
|
|
| Remdesivir |
6 |
42.9 |
|
| Dexamethasone |
5 |
35.7 |
|
| Antibiotics |
9 |
64.3 |
|
| Donor plasma with antibodies |
1 |
7.1 |
|
| SD: Standard deviation; CRP: C-reactive protein; ICU: Intensive care unit. |
